Subscribe to Michael Ryan's Posts
Michael W. Ryan advises manufacturers, health care providers, developers, and investors on the legal, regulatory, and reimbursement issues that arise during the development and commercialization of medical devices, drugs, biological products, and clinical laboratory testing services. Read Michael Ryan's full bio.
By Dale Van Demark, Michael Ryan, Stephen W. Bernstein, Kristian A. Werling, Hamid Yunis, Sharon Lamb, Emmanuelle Trombe and Dr. Stephan Rau on Jun 10, 2021
Posted In Digital Health, Health M&A, Health Private Equity, Life Sciences
Today’s global healthcare marketplace is marked by unprecedented transformation. This presents both challenges and opportunity to today’s market participants. We know how important it is to structure cross-border investments and transactions to account for complex and ever-shifting regulations. Within this dynamic environment, our health lawyers wield a deep knowledge of how healthcare services, medical technology...
By Alva C. Mather, Anisa Mohanty, Gugan Kaur, Michael Ryan and Vernessa T. Pollard on Jan 13, 2020
Posted In FDA, Life Sciences
2019 was a robust year for the US Food and Drug Administration’s (FDA’s) regulatory agenda. The agency continued to implement initiatives and mandates required by the 21st Century Cures Act (Cures Act), and navigated leadership and staffing changes at many levels. Most notably, Commissioner Scott Gottlieb resigned on April 5. Norman Sharpless and Brett Giroir...